http://www.dowjonesmonitor.com/
by Dan Kolber
Post No. 3,157 The following is brought to you by Intellivest Securities Research, Inc. Toward the end of this Blog is a list of the Dow 30 current CEOs, and a recent ranking of the Dow 30 components by market capitalization and a summary of recent Dow 30 components' SEC filings.
A read of the print editions of Wednesday's Wall Street Journal, Financial Times, Investor's Business Daily, New York Times, USA Today, Atlanta Journal & Constitution & Daily Report (Ga. - carries Bloomberg) yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Tuesday's closing stock prices and related data in alphabetical order.
The Dow Jones Industrial Average: The Dow Jones Industrial Average closed Tuesday at 18110.14 up 72.17 or 0.40% from Monday's close of 18037.97. For the year the Dow is up 1.61%. Of the 30 Dow components 19 gained, American Express was unchanged and 10 declined. The biggest gainer dollar-wise was IBM up $3.19 and percentage-wise was Merck up 5.04%. The biggest decliner dollar-wise and percentage-wise was Apple down $2.09 or 1.58%.
WSJ pC4 "Profit reports offset biotech slide" by Corrie Driebusch says US stocks rose slightly Tues. as a round of upbeat quarterly earnings reports helped offset a continued decline in biotech stocks. Merck raised its earnings guidance for the year as its 1Q results declined less than expected.
As of the open of the market on Wednesday the current divisor for the Dow Jones Industrial Average found at page C5 of Wednesday's Wall St. Journal is 0.14985889030177. Wednesday's trailing P/E ratio is 16.41 up from Tuesday's trailing P/E ratio of 16.39 (last year it was 16.13). Wednesday's P/E estimate is 16.30 unchanged from Tuesday's P/E estimate of 16.30 (year ago it was 14.70) and Tuesday's dividend yield is 2.25 down from Monday's dividend yield of 2.25 (last year it was 2.16). The Dow's all-time high was 18288.63 on March 2, 2015. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.
Tuesday's Dow Jones Industrial Average numerator is 2713.97 up 10.82 from Monday's average numerator of 2703.15. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator change for today by the divisor (0.14985889030177) you get the change in today's Dow. A dollar increase or decrease in a Dow stock results in a $6.67 change in the Dow Index.
The average closing price (the closing numerator divided by 30) of Tuesday's Dow Jones Industrial Average was $90.47 up 36 cents from Monday's closing average of $90.11. The median closing price of Tuesday's Dow Jones Industrial Average was $87 (CAT/XOM) up 83 cents from Monday's median closing price of $86.17 (CAT/XOM). The lowest volume was Travelers and the highest volume was Apple.
If Tuesday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have made $1,082 ($271,3397 - $270,315).
4/28/15 Tues. 4:37 pm MarketWatch by Anora Mahmudova and Sara Sjolin says U.S. stocks ended Tuesday’s choppy session mostly higher, with the S&P 500 and Nasdaq Composite closing near record levels reached last week. However, disappointing earnings and weaker-than-expected economic data capped gains on the S&P 500 and Dow industrials, while Nasdaq finished slightly lower. The S&P 500 SPX, +0.28% closed up 5.84 points, or 0.3%, at 2,114.76, with nine of its main sectors finishing higher. The Dow Jones Industrial Average DJIA, +0.40% which had dropped by as much as 120 points in early trading in New York, finished with a gain of 72.17 points, or 0.4%, to 18,110.14. Meanwhile, the tech-laden Nasdaq Composite COMP, -0.10% ended the session 4.82 points, or 0.1%, lower at 5,055.42. James Abate, chief investment officer at Centre Funds, was concerned about markets’ march higher despite deteriorating fundamentals.“Recent economic data indicate contraction and a slowdown in growth. Meanwhile, earnings outlook is for zero growth. It is possible that investors are treating this as ‘bad news is good news’ assuming the Fed will not raise rates at all, given the economy is not doing as well as they hoped it would,” Abate said. “Colin Cieszynski, chief market strategists at CMC Markets, earlier blamed worse-than-expected earnings from companies such as Ford and Whirlpool on selling pressure, when Dow dropped more than 100 points at session lows.“It appears that consumers are not spending on big-ticket items, while confidence also dropped. In the next month or so, if we do not see improved economic numbers, markets might see a deeper correction, as a lot of investors had been expecting consumer spending to pick up,” Cieszynski said.The Federal Reserve Open Market Committee meeting kicked off on Tuesday, but the interest-rate statement isn’t released until Wednesday afternoon at 2 p.m. Eastern Time. Investors will be looking for clues as to whether a near-term rate hike is still in play, although a large majority of Fed watchers don’t think the central bank will provide any hints, preferring to keep all options on the table.For the discussion on Wednesday, the FOMC will have the first-quarter GDP number to include in their assessment of the economy and interest rates.
Wednesday's Dow News followed by Tuesday's Closing Dow Numbers:
American Express:
Apple:
Boeing:
Caterpillar:
Chevron:
Cisco:
Coke:
Disney:
DuPont:
Exxon:
GE:
Goldman Sachs:
Home Depot:
Intel:
IBM:
JPMorgan:
Johnson & Johnson:
McDonald's:
Merck: WSJ pC12 "merck can't shrink to fit its stock" by Charley Grant says Merck's 1Q rev was $9.4 bil down 8% over the year but still beat the average forecast. Adjusted eps of 85 cents also topped views. Merck's stock was up while Pfizer and Bristol-Myers fell.
WSJ pC4 "Profit reports offset biotech slide" by Corrie Driebusch says US stocks rose slightly Tues. as a round of upbeat quarterly earnings reports helped offset a continued decline in biotech stocks. Merck raised its earnings guidance for the year as its 1Q results declined less than expected.
Microsoft:
Nike:
Pfizer: WSJ pC12 "merck can't shrink to fit its stock" by Charley Grant says Merck's 1Q rev was $9.4 bil down 8% over the year but still beat the average forecast. Adjusted eps of 85 cents also topped views. Merck's stock was up while Pfizer and Bristol-Myers fell.
Procter & Gamble:
3M:
Travelers:
United Technologies:
UnitedHealth:
Verizon:
Visa:
Walmart:
Tuesday's Closing Dow Numbers:
| Symbol | Last Sale | Change | % Change | Share Volume | Market |
|---|---|---|---|---|---|
| AXP | NYSE | ||||
| AAPL | ▼ | NASDAQ-GS | |||
| BA | ▼ | NYSE | |||
| CAT | ▲ | NYSE | |||
| CVX | ▲ | NYSE | |||
| CSCO | ▲ | NASDAQ-GS | |||
| KO | ▼ | NYSE | |||
| DIS | ▼ | NYSE | |||
| DD | ▲ | NYSE | |||
| XOM | ▲ | NYSE | |||
| GE | ▲ | NYSE | |||
| GS | ▲ | NYSE | |||
| HD | ▼ | NYSE | |||
| INTC | ▲ | NASDAQ-GS | |||
| IBM | ▲ | NYSE | |||
| JPM | ▲ | NYSE | |||
| JNJ | ▲ | NYSE | |||
| MCD | ▲ | NYSE | |||
| MRK | ▲ | NYSE | |||
| MSFT | ▲ | NASDAQ-GS | |||
| NKE | ▼ | NYSE | |||
| PFE | ▼ | NYSE | |||
| PG | ▼ | NYSE | |||
| MMM | ▲ | NYSE | |||
| TRV | ▲ | NYSE | |||
| UTX | ▲ | NYSE | |||
| UNH | ▲ | NYSE | |||
| VZ | ▲ | DualListed | |||
| V | ▼ | NYSE | |||
| WMT | ▼ | NYSE |
Here are the current CEOs of the Dow 30 Companies:
AT&T T Randall L. Stephenson (Dallas, TX)
Apple: Tim Cook (Cupertino, CA)
American Express AXP Kenneth I. Chenault (NY, NY)
Boeing BA W. James McNerney, Jr. (Chicago, Ill)
Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)
Chevron CVX John Watson (San Ramon, CA)
Cisco CSCO John Chambers (San Jose, CA)
Coca Cola KO Muhtar Kent (Atlanta, GA)
Disney DIS Robert Iger (Burbank, CA)
DuPont DD Ellen Kullman (Wilmington, DE)
ExxonMobil XOM Rex W. Tillerson (Irving, Tx)
GE Jeffrey R. Immelt (Fairfield, CT)
Goldman Sachs GS Lloyd Blankfein (NY, NY)
Home Depot HD Craig Menear (Atlanta, GA)
Intel INTC Brian M. Krzanich (Santa Clara, CA)
IBM Virginia M. Rometty (Armonk, NY)
JPMorgan Chase JPM Jamie Dimon (NY, NY)
Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)
McDonald's MCD Steve Easterbrook (Oak Brook, Ill)
Merck MRK Kenneth Frazier (Whitehouse Station, N.J.)
Microsoft MSFT Satya Nadella (Redmond, WA)
Nike NKE Mark Parker (Beaverton, OR)
Pfizer PFE Ian Read (NY, NY)
Procter & Gamble PG A. G. Lafley (Cincinnati, OH)
3M MMM Inge Thulin (St. Paul, MN)
Travelers TRV Jay S. Fishman (NY, NY)
UnitedHealth UNC Stephen Hemsley (Minnetonka, MN)
United Technologies UTX Greg Hayes (Hartford, CT)
Verizon VZ Lowell McAdam (NY, NY)
Visa V Charles W. Scharf (San Francisco, CA)
Wal-Mart WMT Doug McMillon (Bentonville, ARK)
***************************
Here are the Dow Jones Industrial Average 30 as of 3/22/15 ranked in order of market capitalization in billions:
1. Apple AAPL $733.34
2. Exxon Mobil XOM $354.62
3. Microsoft MSFT 351.78
4. Johnson & Johnson JNJ 284.72
5. Wal-Mart WMT 268.87
6. GE 255.65
7. JPMorgan Chase JPM 229.36
8. Procter & Gamble PG 228.84
9. Pfizer PFE 209.91
10. Verizon VZ 205.94
11. Chevron CVX 201.24
12. Disney 184.28
13. Coke KO 177.49
14. Merck MRK 166.26
15. IBM 160.99
16. Home Depot HD 153.44
17. Cisco CSCO 145.18
18. Intel INTC 144.28
19. UnitedHealth UNH 113.62
20. Boeing BA 108.83
21. United Technologies UTX 108.37
22. 3M MMM 105.68
23. McDonald' s MCD 93.28
24. Nike NKE 88.10
25. Goldman Sachs GS 87.21
26. American Express AXP 84.29
27. DuPont DD 67.31
28. Caterpillar CAT 49.21
29. Visa V 42.35
30. Travelers TRV 35.26
****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 3/22/15 for the prior 90 day period:
Symbol & Co. Name/Date of Filing/Form Filed/ Comments
American Express AXP:
3/16/15 8K re: delinq. & write-off stats for 3 mos. thru 2/15/15
3/11/15 8K re: increase of quarterly dividend & repurchase of up to $6.6 of shares
3/2/15 8K re: issuance of preferred shares
2/24/15 10K re: FY ended 12/31/14
2/17/15 8K re: delinq. & write-off states for 3 months thru 1/15
2/12/15 8K re: end of exclusive deal w/Costco
1/21/15 8K re: 4Q & FY '14 earnings
1/15/15 8K re: delinq. & write-off delinq. stats. for 3 mos ended 12/31/14.
Apple AAPL:
3/13/15 8K re: amdmt. to employee stock purchase plan
2/9/15 8K re: issuance of notes
1/28/15 8K re: change to fin'l stmts due to change of reporting
1/28/15 10Q & 1/27/15 8K re: Qtr. ended 12/27/14
1/22/15 2 14A Proxies re: Annual Mtg of Shareholders on 3/10/15 at 9 am at HG at Cupertino, CA
Boeing BA:
3/13/15 14A Def. Proxy re: Annual Shareholders Mtg on 4/27/15 at 9 am at Field Museum, Chicago
2/20/15 8K re: issuance of senior notes
2/12/15 10K & 1/28/15 8K re: FY ended 12/31/14
2/10/15 8K re: retirement of Linda Z. Cook from Board
1/27/15 8K re: 4Qtr fin'l results
Caterpillar CAT:
3/19/15 8K re: sales thru 2/15
2/19/15 8K re: sales thru 1/15
2/17/15 & 1/27/15 8K re: FY ended 12/31/14
1/27/15 8K re: 4Qtr fin'l results
1/26/15 8K re: 3 mos ended 12/31/14 retail sales stats
Chevron CVX:
3/3/15 8K re: issuance of Floating Rate Notes
2/20/15 10K & 1/30 8K re: FY ended 12/31/14
2/3/15 8K re: election of Jeanette L. Ourada, Corp. VP & Comptroller
1/30/15 8K re: 4Qtr fin'l results
Cisco CSCO:
3/19/15 8K re: exec pre-arranged stock trading plan
2/18/15 & 2/11/15 8K re: 2Qtr ended 1/24/15
Coke KO:
3/2/15 Def. 14A Proxy re: Annual Mtg of Shareholders 11 am, Cobb Galeria Centre, Atlanta
3/10/15 & 3/3/15 8Ks re: issuance of Floating Rate Notes
2/25/15 10K & 2/10/15 8K re: FY ended 12/31/14
2/20/15 8K re: retirement from Board of James D. Robinson & Peter V. Ueberroth
2/18/15 8K re: Amdmt to employee stock option plans
Disney DIS:
3/13/15 8K re: voting results of 3/12 Annual Shareholders Mtg
2/11/15 Def14A re: shareholder proposals
2/5/15 8K re: Agreement for COO Thomas O. Stagg
2/3/15 10Q & 2/3/15 8K re: Qtr ended 12/27/14
1/16/15 Def. 14A Proxy re: Annual Mtg. of Shareholders at 10 am 3/12/15 at Palace of Fine Arts, SF
DuPont DD:
3/17/15 - 3/19/15 Def. Proxy 14A re: Trian's proposal to add Directors
2/5/15 8K re: election to Board of Edward D. Breent & James L. Gallogly
2/5/15 10K & 1/27/15 8K re: FY ended 12/31/14
1/27/15, 1/15/15, 1/14/15, 1/13/15, 1/9/15 (five) 14A Proxy: re: Nelson Peltz's Trian's proposal to break-up DuPont
1/12/15 8K re: 4Qtr fin'l results
ExxonMobil XOM:
3/10/15 8K re: 3/4/15 analyst meeting
3/6/15 8K re: issuance of Floating rate Notes
2/25/15 10K & 2/24/15 8K & 2/2/15 8K re: 10K for FY ended 12/31/14
GE:
3/10/15 def. 14A Proxy re: Shareholder Mtg 4/22/15 10am at Cox Conv. Ctr. Oklahoma City
2/27/15 10K re: FY ended 12/31/14
2/11/15 8K re: Amdmt By-laws re: proxy access by 3% holders
1/23/15 8K re: 4Qtr fin'l results
Goldman Sachs GS:
3/11/15 8K re: revised '15 Capital Plan
3/9/15 8K re: retirement from Board of Claes Dahlback
2/23/15 10K & 1/16/15 8K re: FY ended 12/31/15
2/8/15 8K re: issuance of Floating Rate Notes
1/23/15 8K re: issuance of notes
1/16/15 8K re: 4Qtr fin'l results
Home Depot HD:
2/24/15 8K re: FY & Qtr ended 2/1/15
1/16/15 8K re: replacement of Chairman of Board Francis S. Blake with Craig A. Menear
Intel INTC:
3/12/15 8K re: 1Qtr guidance
2/13/15 10K & 1/15/15 8K re: FY ended 12/27/14
1/15/15 8K re: fin'l results of 4Qtr ended 12/27
IBM:
3/19/15 Def. Proxy 14A Stockholders Annual Mtg at 10 am 4/.28/15 at Statehouse Conv. Ctr., Little Rock, Ark & nomination of Alex Gorsky, CEO, Johnson & Johnson & Peter R. Voser to Board
2/24/15 10K & 1/20/15 8K re: FY ended 12/31/14
2/5/15 8K re: issuance of debt securities
1/30/15 8K re: compensation amounts for execs for 2014
1/21/15 & 1/20/15 8Ks re: 4Qtr ended 12/31/14 fin'l results
1/7/15 8K re: exec promotions and amendment to bylaws to increase Board to 14 & election of Peter R. Voser to Bd
JPMorgan Chase JPM:
3/20/15 8K & 3/6/15 8K re: redemption of Bear Stearn Notes
3/6/15 8K re: release of '15 Dodd-Frank Act Stress Test results
2/27/15 8K re: redemption of Capital securities
2/25/15 8K re: 2/24/15 Investor Day Conf.
2/24/15 10K for FY ended 12/31/14
2/17/15 8K re: redemption of notes
2/12/15 8K re: issuance of Preferred Shares
1/23/15 8K re: closing of note offering
Johnson & Johnson JNJ:
3/11/15 Def. 14A Proxy for Annual shareholder Mtg a 10:30 am on 4/23/15 at State Theatre, New Brunswick, NJ
3/2/15 8K re: sale of Cordis Business for $1.99 bil to Cardinal Health
2/24/15 10K for FY ended 12/28/14
1/20/15 8K re: 4Qtr ended 12/28/14 fin'l results
McDonald's MCD:
3/20/15 8K re: stock award to execs
3/9/15 8K re: Feb. global sales
3/3/15 8K & 2/3/15 8K re: election of Stephen Easterbrook as CEO
2/24/15 10K for FY ended 12/31/14
2/10/15 8K re: Global sales for Jan.
2/4/15 8K re: TRC mini-tender offer
1/23/15 8K re: 4Qtr ended 12/31/14 fin'l results
Merck MRK:
2/27/15 10K & 2/4/15 8K re: FY ended 12/31/14
2/10/15 8K re: issuance of Floating rate Notes
Microsoft MSFT:
2/12/15 8K re: issuance of notes
1/26/15 10Q & 1/26/15 8K re: fin'l results for qtr ended 12/31/14
Nike NKE:
3/19/15 8K for Qtr ended 2/28/15
2/12/15 8K re: election & retirement of VPs
1/7/15 10Q & 12/2214 8K re: results of qtr ended 11/30
Pfizer PFE:
3/12/15 Def. 14A Proxy re: 4/23/15 Annual Shareholder Mtg at Short Hills, NJ
2/27/15 10K & 1/27/15 8K re: FY ended 12/31/15
2/10/15 8K re: $5 bil share buyback program
2/6/15 8K re: purchase of Hospira, Inc.
11/6/14 10Q for quarter ended 9/28/14
11/6/14 10Q & 10/28/14 8K re: 3Qtr ended 9/28/14
Procter & Gamble PG:
2/19/15 8K re: Consumer analysts Group conf. on 2/19/15
2/10/15 8K re: appointment of ex-Home depot CEO Frank S. Blake to Board
1/27/15 10Q & 1/27/15 8K re: 2Qtr ended 12/31/14 fin'l results
1/13/15 8K re: quarterly div. of 0.6436 cents payable 2/17 to record holders as of close of business
3M MMM:
2/23/15 8K purchase of Polypore's separation Media business
2/12/15 10K & 1/27/15 8K re: FY ended 12/31/14
1/31/15 8K re: 4Qtr fin'l results
Travelers TRV:
2/12/15 10K re: FY ended 12/31/14
1/22/15 8K re: qtr ended 12/31/14 fin'l results
United Technologies UTX:
3/13/15 Def. 14A Proxy re: Annual Mtg of Shareholders on 3/2/15 2pm at PGA Nat'l Resort, Palm Beach Gardens, FL
3/1/13/15 8K re: repurchase of $2.6 bil of stock
2/5/15 10K for FY ended 12/31/15
3/12/15 8K re: reviewing possible spin-off of Sikorsky Aircraft Business
1/26/15 8K re: 4Qtr fin'l results
1/23/15 8K re: separation agreement for ex-CEO Louis Chenevert
1/15/15 8K re: departure of exec Alain M. Bellemare
UnitedHealth Group UNH:
3/6/15 8K re: Barclays Global Healthcare Conf on 3/10 in Miami
2/17/15 8K re: exec. comp. changes
2/10/15 10K re: FY ended 12/31/14
2/6/15 8K re: Leenik Global Healthcare Conf. on 2/11
1/21/15 8K re: 4Qtr fin'l results
Verizon Communications Inc. VZ:
3/12/15 8K & 2/26/15 8K & 2/25/15 8K 2/12/15 8K re: results of exchange offer
2/23/15 10K re: FY ended 12/31/14
2/18/15 8K re: EVP changes
2/5/15 8K re: election of Mark T. Bertolini to Board
2/5/15 8K re: sale of assets, purchase of wireless towers & $5 bil stock buybacks
1/30/15 8K re: results of bidding for AWS-3 spectrum licenses in FCC auction
1/22/15 & 1/16/15 8Ks re: 4Qtr fin'l results
1/14/15 8K re: retirement from Board of Robert W. Lane
Visa V:
2/27/15 8K & two 1/29/15 8Ks: re: amd. by-laws to allow 4 for 1 stock splits
2/2/15 8K re: exec. changes
1/29/15 10Q & 1/29/15 8K re: 1Qtr ended 2/31/14 fin'l results
1/29/15 8K, 1/21/15 Proxy & 1/14/15 Proxy re: amendment of Cert of Incorp. for stock split
1/28/15 8K re: dividend of 48 cents payable 3/3 for record holders on 2/13
WalMart WMT:
2/19/15 8K re: 4Q results
12/16/14 8K re: latest ruling re: class action lawsuit in Phil for underpaying employees - Braun/Hummel v. Walmart
NO MAS
No comments:
Post a Comment